{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:33:31Z","timestamp":1790876011328,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"China Rehabilitation Research Center","award":["NO.2017ZX-02"],"award-info":[{"award-number":["NO.2017ZX-02"]}]},{"name":"Capital's Funds for Health Improvement and Research","award":["NO.2018-3-6012"],"award-info":[{"award-number":["NO.2018-3-6012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00198-020-05807-0","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:03:07Z","timestamp":1609585387000},"page":"1117-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"32","author":[{"given":"Y.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"issue":"1","key":"5807_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.26599\/jnr.2018.9040014","volume":"6","author":"J Xie","year":"2018","unstructured":"Xie J, Deng X, Feng Y, Cao N, Zhang X, Fang F, Zhang S, Feng Y (2018) Early intradural microsurgery improves neurological recovery of acute spinal cord injury: a study of 87 cases. J Neurorestoratol 6(1):152\u2013157. https:\/\/doi.org\/10.26599\/jnr.2018.9040014","journal-title":"J Neurorestoratol"},{"issue":"1","key":"5807_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/jn.S143236","volume":"6","author":"Y Kang","year":"2018","unstructured":"Kang Y, Ding H, Zhou H, Wei Z, Liu L, Pan D, Feng S (2018) Epidemiology of worldwide spinal cord injury: a literature review. J Neurorestoratol 6(1):1\u20139. https:\/\/doi.org\/10.2147\/jn.S143236","journal-title":"J Neurorestoratol"},{"issue":"5","key":"5807_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.bone.2004.01.001","volume":"34","author":"P Eser","year":"2004","unstructured":"Eser P, Frotzler A, Zehnder Y, Wick L, Knecht H, Denoth J, Schiessl H (2004) Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals. Bone 34(5):869\u2013880. https:\/\/doi.org\/10.1016\/j.bone.2004.01.001","journal-title":"Bone"},{"key":"5807_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jor.1100100309","volume":"10","author":"DE Garland","year":"1992","unstructured":"Garland DE (1992) Osteoporosis after spinal cord injury. J Orthop Res 10:371\u2013378","journal-title":"J Orthop Res"},{"issue":"6","key":"5807_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acscentsci.9b00220","volume":"5","author":"M Minoshima","year":"2019","unstructured":"Minoshima M, Kikuta J, Omori Y, Seno S, Suehara R, Maeda H, Matsuda H, Ishii M, Kikuchi K (2019) In vivo multicolor imaging with fluorescent probes revealed the dynamics and function of osteoclast proton pumps. ACS Cent Sci 5(6):1059\u20131066. https:\/\/doi.org\/10.1021\/acscentsci.9b00220","journal-title":"ACS Cent Sci"},{"issue":"2","key":"5807_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00198-005-2028-8","volume":"17","author":"SD Jiang","year":"2006","unstructured":"Jiang SD, Dai LY, Jiang LS (2006) Osteoporosis after spinal cord injury. Osteoporos Int 17(2):180\u2013192. https:\/\/doi.org\/10.1007\/s00198-005-2028-8","journal-title":"Osteoporos Int"},{"issue":"8","key":"5807_CR7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00586-017-5114-7","volume":"27","author":"S Soleyman-Jahi","year":"2018","unstructured":"Soleyman-Jahi S, Yousefian A, Maheronnaghsh R, Shokraneh F, Zadegan SA, Soltani A, Hosseini SM, Vaccaro AR, Rahimi-Movaghar V (2018) Evidence-based prevention and treatment of osteoporosis after spinal cord injury: a systematic review. Eur Spine J 27(8):1798\u20131814. https:\/\/doi.org\/10.1007\/s00586-017-5114-7","journal-title":"Eur Spine J"},{"key":"5807_CR8","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/BF01623222","volume":"3","author":"H Fleisch","year":"1993","unstructured":"Fleisch H (1993) New bisphosphonates in osteoporosis. Osteoporos Int 3:S15\u2013S22","journal-title":"Osteoporos Int"},{"issue":"9","key":"5807_CR9","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/annonc\/mds009","volume":"23","author":"T Brodowicz","year":"2012","unstructured":"Brodowicz T, O\u2019Byrne K, Manegold C (2012) Bone matters in lung cancer. Ann Oncol 23(9):2215\u20132222. https:\/\/doi.org\/10.1093\/annonc\/mds009","journal-title":"Ann Oncol"},{"issue":"35","key":"5807_CR10","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1200\/JCO.2017.73.7437","volume":"35","author":"CL Shapiro","year":"2017","unstructured":"Shapiro CL, Moriarty JP, Dusetzina S, Himelstein AL, Foster JC, Grubbs SS, Novotny PJ, Borah BJ (2017) Cost-effectiveness analysis of monthly zoledronic acid, zoledronic acid every 3 months, and monthly denosumab in women with breast cancer and skeletal metastases. J Clin Oncol 35(35):3949\u20133955. https:\/\/doi.org\/10.1200\/JCO.2017.73.7437","journal-title":"J Clin Oncol"},{"key":"5807_CR11","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"issue":"5","key":"5807_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/cre2.79","volume":"3","author":"A Jokstad","year":"2017","unstructured":"Jokstad A (2017) Cochrane Collaboration Systematic Reviews may be based on trials not approved by a research ethics committee. Clin Exp Dent Res 3(5):179\u2013182","journal-title":"Clin Exp Dent Res"},{"key":"5807_CR13","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.apmr.2012.02.023","volume":"93","author":"KV Chang","year":"2012","unstructured":"Chang KV, Chen SY, Chen WS, Tu YK, Chien KL (2012) Comparative effectiveness of focused shock wave therapy of different intensity levels and radial shock wave therapy for treating plantar fasciitis: a systematic review and network meta-analysis. Arch Phys Med Rehabil 93:1259\u20131268. https:\/\/doi.org\/10.1016\/j.apmr.2012.02.023","journal-title":"Arch Phys Med Rehabil"},{"key":"5807_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. https:\/\/doi.org\/10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"5807_CR15","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.3892\/etm.2019.7897","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Ma J, Zhao T, Gao F, Sun W (2019) Application and efficacy of extracorporeal shockwave treatment for knee osteoarthritis: a systematic review and meta-analysis. Exp Ther Med 18(4):2843\u20132850. https:\/\/doi.org\/10.3892\/etm.2019.7897","journal-title":"Exp Ther Med"},{"issue":"7","key":"5807_CR16","doi-asserted-by":"publisher","first-page":"e39471","DOI":"10.1371\/journal.pone.0039471","volume":"7","author":"K Thorlund","year":"2012","unstructured":"Thorlund K, Imberger G, Johnston BC, Walsh M, Awad T, Thabane L, Gluud C, Devereaux PJ, Wetterslev J (2012) Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses. PLoS One 7(7):e39471","journal-title":"PLoS One"},{"issue":"3","key":"5807_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/wps.20672","volume":"18","author":"J Firth","year":"2019","unstructured":"Firth J, Teasdale SB, Allott K, Siskind D, Marx W, Cotter J, Veronese N, Schuch F, Smith L, Solmi M, Carvalho AF, Vancampfort D, Berk M, Stubbs B, Sarris J (2019) The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 18(3):308\u2013324. https:\/\/doi.org\/10.1002\/wps.20672","journal-title":"World Psychiatry"},{"issue":"1","key":"5807_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA (2007) Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 26(1):53\u201377","journal-title":"Stat Med"},{"issue":"39","key":"5807_CR19","doi-asserted-by":"publisher","first-page":"e17321","DOI":"10.1097\/MD.0000000000017321","volume":"98","author":"HR Park","year":"2019","unstructured":"Park HR, Kim JH, Lee D, Jo HG (2019) Cangfu daotan decoction for polycystic ovary syndrome: a protocol of systematic review and meta-analysis. Medicine (Baltimore) 98(39):e17321. https:\/\/doi.org\/10.1097\/MD.0000000000017321","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"5807_CR20","doi-asserted-by":"publisher","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","volume":"10","author":"SC Palmer","year":"2013","unstructured":"Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF (2013) Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med 10(4):e1001436. https:\/\/doi.org\/10.1371\/journal.pmed.1001436","journal-title":"PLoS Med"},{"issue":"3","key":"5807_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1682\/JRRD.2004.05.0062","volume":"42","author":"WA Bauman","year":"2005","unstructured":"Bauman WA, Wecht JM, Kirshblum S, Spungen AM, Morrison N, Cirnigliaro C, Schwartz E (2005) Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev 42(3):305\u2013313. https:\/\/doi.org\/10.1682\/JRRD.2004.05.0062","journal-title":"J Rehabil Res Dev"},{"issue":"1","key":"5807_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FR, Ferguson-Pell M, Swaminathan R, Keen RW (2011) Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int 22(1):271\u2013279. https:\/\/doi.org\/10.1007\/s00198-010-1221-6","journal-title":"Osteoporos Int"},{"issue":"4","key":"5807_CR23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1210\/jc.2006-2013","volume":"92","author":"NL Gilchrist","year":"2007","unstructured":"Gilchrist NL, Frampton CM, Acland RH, Nicholls MG, March RL, Maguire P, Heard A, Reilly P, Marshall K (2007) Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 92(4):1385\u20131390. https:\/\/doi.org\/10.1210\/jc.2006-2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5807_CR24","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41393-018-0195-7","volume":"56","author":"S Goenka","year":"2018","unstructured":"Goenka S, Sethi S, Pandey N, Joshi M, Jindal R (2018) Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial. Spinal Cord 56(12):1207\u20131211. https:\/\/doi.org\/10.1038\/s41393-018-0195-7","journal-title":"Spinal Cord"},{"issue":"6","key":"5807_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.sc.3101725","volume":"43","author":"CM Moran De Brito","year":"2005","unstructured":"Moran De Brito CM, Battistella LR, Saito ET, Sakamoto H (2005) Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study. Spinal Cord 43(6):341\u2013348. https:\/\/doi.org\/10.1038\/sj.sc.3101725","journal-title":"Spinal Cord"},{"key":"5807_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41393-020-0431-9","volume":"58","author":"CV Oleson","year":"2020","unstructured":"Oleson CV, Marino RJ, Formal CS, Modlesky CM, Leiby BE (2020) The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study. Spinal Cord 58:921\u2013929. https:\/\/doi.org\/10.1038\/s41393-020-0431-9","journal-title":"Spinal Cord"},{"issue":"9","key":"5807_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.pmrj.2016.01.012","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D (2016) Zoledronic acid treatment after acute spinal cord injury: results of a randomized, placebo-controlled pilot trial. Pm r 8(9):833\u2013843. https:\/\/doi.org\/10.1016\/j.pmrj.2016.01.012","journal-title":"Pm r"},{"issue":"5","key":"5807_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, Caminis J (2007) Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int 80(5):316\u2013322. https:\/\/doi.org\/10.1007\/s00223-007-9012-6","journal-title":"Calcif Tissue Int"},{"issue":"1-2","key":"5807_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1615\/CritRevPhysRehabilMed.2016018768","volume":"28","author":"SM Varghese","year":"2016","unstructured":"Varghese SM, Chandy BR, Thomas R, Tharion G (2016) Effect of zoledronic acid on osteoporosis after chronic spinal cord injury: a randomized controlled trial. Crit Rev Phys Rehabil Med 28(1-2):85\u201393. https:\/\/doi.org\/10.1615\/CritRevPhysRehabilMed.2016018768","journal-title":"Crit Rev Phys Rehabil Med"},{"issue":"312","key":"5807_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"7041","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 7041(312):1254\u20131259. https:\/\/doi.org\/10.1136\/bmj.312.7041.1254","journal-title":"BMJ"},{"issue":"3","key":"5807_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/10790268.2004.11753748","volume":"27","author":"DE Garland","year":"2004","unstructured":"Garland DE, Adkins RH, Kushwaha V, Stewart C (2004) Risk factors for osteoporosis at the knee in the spinal cord injury population. J Spinal Cord Med 27(3):202\u2013206. https:\/\/doi.org\/10.1080\/10790268.2004.11753748","journal-title":"J Spinal Cord Med"},{"issue":"4","key":"5807_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","volume":"33","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cirnigliaro CM, La Fountaine MF, Martinez LA, Kirshblum SC, Spungen AM (2015) Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study. J Bone Miner Metab 33(4):410\u2013421. https:\/\/doi.org\/10.1007\/s00774-014-0602-x","journal-title":"J Bone Miner Metab"},{"key":"5807_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1210\/er.2001-2002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi JD, Shea B, Tugwell P, Guyatt G (2002) Metaanalyses of therapies for postmenopausal osteoporosis. II. Metaanalysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508\u2013516","journal-title":"Endocr Rev"},{"issue":"80","key":"5807_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0003-9993(99)90133-8","volume":"3","author":"PW Nance","year":"1999","unstructured":"Nance PW, Schryvers O, Leslie W, Ludwig S, Krahn J, Uebelhart D (1999) Intravenous pamidronate attenuates bone density loss after acute spinal cord injury. Arch Phys Med Rehabil 3(80):243\u2013251","journal-title":"Arch Phys Med Rehabil"},{"issue":"7","key":"5807_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1359\/JBMR.040313","volume":"19","author":"Y Zehnder","year":"2004","unstructured":"Zehnder Y, Risi S, Michel D, Knecht H, Perrelet R, Kraenzlin M, Z\u00e4ch GA, Lippuner K (2004) Prevention of bone loss in paraplegics over 2 years with alendronate. J Bone Miner Res 19(7):1067\u20131074. https:\/\/doi.org\/10.1359\/JBMR.040313","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05807-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:05:03Z","timestamp":1621267503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05807-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5807"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05807-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Analyses were conducted using Review Manager 5.3 software ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}